Results 141 to 150 of about 1,796 (202)

Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds". [PDF]

Front Pharmacol
Rashad Y, Alt EU, Izadpanah R, Qin X, Braun SE.   +4 more
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report. [PDF]

Iran J Pathol
Nayeri F, Nematolahi P, Mohamadi B.
europepmc   +1 more source

Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene. [PDF]

Cancer Cell Int
Li R, Kuang W, Yang H, Zhang B, Zhao K, Fang W, Cheng Z, Fu X, Peng H.   +8 more
europepmc   +1 more source

Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]

Cancers (Basel)
Solana-Altabella A, Navarro-Vicente I, Rodríguez-Arbolí E, Noriega V, Serrano J, Bernal T, Carrasco-Baraja V, Garcia-Boyero R, Olivier Cornacchia C, Algarra L, López-Briz E, Mena-Durán A, Solano-Tovar J, Botella-Prieto C, Sánchez-Sánchez S, Bergua-Burgues JM, Lloret-Madrid P, Rodenas-Rovira M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Centelles-Oria M, Poveda-Andrés JL, Martínez-Cuadrón D, Montesinos P.   +26 more
europepmc   +1 more source

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience. [PDF]

Oncotarget
Fei F, Telatar M, Tomasian V, Chang L, Danilova O, Arias-Stella J, Pillai R, Soma L, Tizro P, Becker PS, Stein AS, Marcucci G, Afkhami M.   +12 more
europepmc   +1 more source

Precursor Dendritic Cell Proliferation in Multiple Myeloma: A Precursor to Acute Myeloid Leukemia. [PDF]

Hematol Rep
Reberšek K, Anžej Doma S, Škerget M, Podgornik H.   +3 more
europepmc   +1 more source

Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program. [PDF]

Ann Hematol
Herling M, Angelucci E, Benoit TM, Rivoli G, Curti A, Götze KS, Wirths S, Erakli D, Zuurman M, Deconinck E.   +9 more
europepmc   +1 more source

Care Optimization for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Receiving Tagraxofusp. [PDF]

J Adv Pract Oncol
Faysman K, Rubin J, Lubas A, Kujawa T, Hinojosa G, Marx KR, Katsetos J, Galinsky IA.   +7 more
europepmc   +1 more source

Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Leuk Res Rep
Bashir Q, Konopleva M, Abueg G, Ramdial J, Hosing C, Srour SA, Alousi A, Popat UR, Nieto Y, Alatrash G, Champlin RE, Shpall EJ, Qazilbash M, Pemmaraju N.   +13 more
europepmc   +1 more source